Literature DB >> 7972227

3F8 monoclonal antibody treatment of patients with stage IV neuroblastoma: a phase II study.

N K Cheung1, B H Kushner, S J Yeh, S M Larson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7972227

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


× No keyword cloud information.
  5 in total

Review 1.  New aspects of neuroblastoma treatment: ASPHO 2011 symposium review.

Authors:  Peter E Zage; Chrystal U Louis; Susan L Cohn
Journal:  Pediatr Blood Cancer       Date:  2012-02-29       Impact factor: 3.167

Review 2.  Biosynthesis and functions of gangliosides: recent advances.

Authors:  K O Lloyd; K Furukawa
Journal:  Glycoconj J       Date:  1998-07       Impact factor: 2.916

Review 3.  Strategies for the targeted delivery of therapeutics for osteosarcoma.

Authors:  Dennis P M Hughes
Journal:  Expert Opin Drug Deliv       Date:  2009-12       Impact factor: 6.648

4.  Intratumoral immunocytokine treatment results in enhanced antitumor effects.

Authors:  Erik E Johnson; Hillary D Lum; Alexander L Rakhmilevich; Brian E Schmidt; Meghan Furlong; Ilia N Buhtoiarov; Jacquelyn A Hank; Andrew Raubitschek; David Colcher; Ralph A Reisfeld; Stephen D Gillies; Paul M Sondel
Journal:  Cancer Immunol Immunother       Date:  2008-04-26       Impact factor: 6.968

5.  Using a combination of gangliosides and cell surface vimentin as surface biomarkers for isolating osteosarcoma cells in microfluidic devices.

Authors:  Henrietta O Fasanya; Pablo J Dopico; Zachary Yeager; Z Hugh Fan; Dietmar W Siemann
Journal:  J Bone Oncol       Date:  2021-03-24       Impact factor: 4.491

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.